Literature DB >> 11495183

Posttraumatic stress disorder arising after road traffic collisions: patterns of response to cognitive-behavior therapy.

S Taylor1, I C Fedoroff, W J Koch, D S Thordarson, G Fecteau, R M Nicki.   

Abstract

Road traffic collisions (RTCs) are common precipitants of posttraumatic stress disorder (PTSD). Two preliminary studies suggest that cognitive-behavior therapy (CBT) is, on average, effective in treating this disorder, although the major patterns of treatment outcome remain to be identified. Such outcomes might include treatment response, partial response, and response followed by relapse. To identify these patterns. 50 people with RTC PTSD completed a 12-week course of CBT, with outcome assessment extending to 3-month follow up. Dynamic cluster analyses revealed 2 replicable patterns of outcome: one for responders (n = 30) and one for partial responders (n = 20). Partial responders, compared with responders, tended to have more severe pretreatment numbing symptoms and greater anger about their RTC, along with lower global levels of functioning, greater pain severity and interference, and greater depression and were more likely to be taking psychotropic medications. Responders and partial responders did not differ in homework adherence, number of sessions attended, therapist effects, or stressors occurring during therapy or in the presence or absence of RTC-related litigation. Implications for enhancing treatment outcome are discussed.

Entities:  

Mesh:

Year:  2001        PMID: 11495183

Source DB:  PubMed          Journal:  J Consult Clin Psychol        ISSN: 0022-006X


  41 in total

1.  Modeling the complexity of post-treatment drinking: it's a rocky road to relapse.

Authors:  Katie Witkiewitz; G Alan Marlatt
Journal:  Clin Psychol Rev       Date:  2007-01-18

2.  Group Cognitive Behavioral Treatment for PTSD: Treatment of Motor Vehicle Accident Survivors.

Authors:  J Gayle Beck; Scott F Coffey
Journal:  Cogn Behav Pract       Date:  2005

3.  Do You Need To Talk About It? Prolonged Exposure for the Treatment of Chronic PTSD.

Authors:  Afsoon Eftekhari; Lisa R Stines; Lori A Zoellner
Journal:  Behav Anal Today       Date:  2006-01-01

4.  Identifying Trajectories and Predictors of Response to Psychotherapy for Post-Traumatic Stress Disorder in Adults: A Systematic Review of Literature.

Authors:  Michelle Dewar; Alison Paradis; Christophe A Fortin
Journal:  Can J Psychiatry       Date:  2019-09-19       Impact factor: 4.356

5.  The role of central amygdala corticotropin-releasing factor in predator odor stress-induced avoidance behavior and escalated alcohol drinking in rats.

Authors:  Marcus M Weera; Allyson L Schreiber; Elizabeth M Avegno; Nicholas W Gilpin
Journal:  Neuropharmacology       Date:  2020-01-25       Impact factor: 5.250

6.  Concurrent treatment of posttraumatic stress disorder and alcohol dependence: Predictors and moderators of outcome.

Authors:  Laurie J Zandberg; David Rosenfield; Carmen P McLean; Mark B Powers; Anu Asnaani; Edna B Foa
Journal:  J Consult Clin Psychol       Date:  2015-10-12

7.  The driving behavior survey as a measure of behavioral stress responses to MVA-related PTSD.

Authors:  Aaron S Baker; Scott D Litwack; Joshua D Clapp; Gayle Beck; Denise M Sloan
Journal:  Behav Ther       Date:  2014-05

8.  Post-traumatic stress in patients with injury-related chronic pain participating in a multimodal pain rehabilitation program.

Authors:  Britt-Marie Stålnacke; Anna Ostman
Journal:  Neuropsychiatr Dis Treat       Date:  2010-03-24       Impact factor: 2.570

9.  Modeling PTSD symptom clusters, alcohol misuse, anger, and depression as they relate to aggression and suicidality in returning U.S. veterans.

Authors:  Julianne C Hellmuth; Cynthia A Stappenbeck; Katherine D Hoerster; Matthew Jakupcak
Journal:  J Trauma Stress       Date:  2012-10

10.  Trajectories of response to treatment for posttraumatic stress disorder.

Authors:  Nathan R Stein; Benjamin D Dickstein; Jennifer Schuster; Brett T Litz; Patricia A Resick
Journal:  Behav Ther       Date:  2012-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.